Drug Type Small molecule drug |
Synonyms (-)-DDMS, (-)-didesmethylsibutramine, (S)-Sibutramine metabolite + [5] |
Action antagonists |
Mechanism Dopamine reuptake inhibitors, adrenergic receptor antagonists(Adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H22ClN |
InChIKeyWQSACWZKKZPCHN-AWEZNQCLSA-N |
CAS Registry229639-57-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | (-)-Desmethylsibutramine | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Erectile Dysfunction | Phase 2 | - | - | |
Female sexual dysfunction | Phase 2 | United States | - | - |
Male sexual dysfunction | Phase 2 | United States | - | - |
Urinary Incontinence, Stress | Phase 2 | - | - |